Imaging

Gareth Lema, MD, PhD, discusses an innovative eye stroke program at Mount Sinai Health System that involves collaboration among ophthalmologists, the stroke service, and emergency department physicians.

Eyes of mice lacking protective protein show signs similar to age-related macular degeneration.

According to the company, new imaging options presenting opportunity for better outcomes for patients.

The effects of cataract surgery are generally evaluated based on improvements in vision, but investigators sought to identify if the structures in the back of the eye were affected as well.

The American Society of Retina Specialists held its 40th Annual Meeting in New York, New York, from July 13-16, 2022. While data was presented for all topics in retina, new revelations in age-related macular degeneration, diabetic retinopathy, and diabetic macular edema dominated the conversation.

Researchers at the University of Strathclyde have developed an affordable device which takes 3D images and could shift the landscape of eye screening and treatment around the world.

At ASRS in New York City, New York, Justis Ehlers, MD, presented a talk entitled, “Higher Order OCT Feature Assessments of the Impact of Fluid Dynamics on Visual Acuity in Neovascular AMD in a Phase III Clinical Trial: The Importance of Outer Retinal Integrity.” Here he discusses the findings.

The 40th annual Scientific Meeting of the American Society of Retina Specialists is scheduled for July 13-16, 2022, in New York.

Richard Rosen, MD, shares insights on how imaging can capture hyalocytes and their movement without the use of dyes.

David Boyer, MD, discusses the Phase 3 investigation for OPT-302 combination therapy for wet AMD.

Genetic and clinical research reveals new type of macular dystrophy, a cause of central vision loss.

The study investigates 3-year intravitreal implant in eyes with active noninfectious posterior uveitis.

The research from eye care nonprofit Orbis International focuses on diabetic retinopathy in Rwanda, where associated vision complications from diabetes are growing.

The study assesses retinal blood biomarkers using a new prototype OCT, aiming to measure retinal biomarkers such as blood flow volume, average velocity, and vessel diameter with a new prototype.

With clearer imaging and enhanced resolution, the new OCT approach could improve medical diagnostic imaging.

With clearer imaging and enhanced resolution, the new OCT approach could improve medical diagnostic imaging.

The rare disorder is often a delayed or misdiagnosed condition, resulting in unnecessary referrals and imaging.

Yasha S. Modi, MD, discusses his best tips and tricks for finding and diagnosing infectious uveitis.

A new technique will allow fast and non-invasive assessment of the physiological state of the retina. This could be a real breakthrough in the treatment of eye diseases.

Retina Technologies Inc. is working on a modular digital vision screening platform it says will provide vision testing for the early detection of eye disorders.

In a patient survey, 66% of respondents said AI plays a large role in their diagnosis and treatment and thought it was important.

In a patient survey, 66% of respondents said AI plays a large role in their diagnosis and treatment and thought it was important.

TAKE-HOME: This affordable device allows the view through a slit lamp to be shared in real time or recorded, for teaching and reference purposes.

Results from our recent poll regarding Retina World Congress 2022 attendance indicate that while many retina specialists will attend the Congress, the majority will not be in Fort Lauderdale, Florida.